• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[铜绿假单胞菌败血症的预防与抗生素治疗]

[Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia].

作者信息

Deng G H

机构信息

Peking Union Medical College Hospital, Beijing.

出版信息

Zhonghua Yi Xue Za Zhi. 1993 Oct;73(10):599-601, 637.

PMID:8313182
Abstract

Thirty-six cases of pseudomonas aeruginosa septicemia were found in 5 years from 1986 to 1990. The main risk factors predisposing septicemia included severe underlying diseases and local primary infection or impaired anatomic barrier. The use of broad-spectrum antibiotics, cytotoxic or immunosuppressive therapy, and leukopenia were also important risk factors. The percentages of in vitro resistant strains to 8 antipseudomonal antibiotics varied from 18% to 47%. The overall effective rate was 42% in 26 patients receiving appropriate antibiotic therapy. The mortality attributable to pseudomonas aeruginosa septicemia was 61%. The prevention and antibiotic treatment of pseudomonas aeruginosa septicemia are discussed.

摘要

1986年至1990年的5年间共发现36例铜绿假单胞菌败血症。引发败血症的主要危险因素包括严重的基础疾病、局部原发性感染或解剖屏障受损。使用广谱抗生素、细胞毒性或免疫抑制疗法以及白细胞减少也是重要的危险因素。体外对8种抗假单胞菌抗生素耐药菌株的百分比在18%至47%之间。26例接受适当抗生素治疗的患者总体有效率为42%。铜绿假单胞菌败血症所致死亡率为61%。本文讨论了铜绿假单胞菌败血症的预防和抗生素治疗。

相似文献

1
[Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia].[铜绿假单胞菌败血症的预防与抗生素治疗]
Zhonghua Yi Xue Za Zhi. 1993 Oct;73(10):599-601, 637.
2
Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.与经验性抗铜绿假单胞菌抗生素治疗持续时间相关的高度耐药铜绿假单胞菌的出现
Clin Perform Qual Health Care. 1999 Apr-Jun;7(2):83-7.
3
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.头孢吡肟替代给药策略对阴沟肠杆菌、弗氏柠檬酸杆菌和铜绿假单胞菌所致肺部及血流感染的影响:一项单中心、开放标签、前瞻性观察性研究。
Clin Ther. 2009 Feb;31(2):299-310. doi: 10.1016/j.clinthera.2009.02.015.
4
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.铜绿假单胞菌血症:死亡危险因素及有效抗菌治疗延迟应用对临床结局的影响
Clin Infect Dis. 2003 Sep 15;37(6):745-51. doi: 10.1086/377200. Epub 2003 Aug 23.
5
Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.铜绿假单胞菌菌血症的治疗与转归:抗生素药效学分析
J Antimicrob Chemother. 2003 Oct;52(4):668-74. doi: 10.1093/jac/dkg403. Epub 2003 Sep 1.
6
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates.既往抗生素治疗暴露对铜绿假单胞菌血流感染分离株药敏模式的影响。
Clin Infect Dis. 2001 Dec 1;33(11):1859-64. doi: 10.1086/324346. Epub 2001 Oct 24.
7
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.铜绿假单胞菌血症的流行病学及转归,特别强调抗生素治疗的影响。对189例病例的分析。
Arch Intern Med. 1996 Oct 14;156(18):2121-6.
8
Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.耐氟喹诺酮类铜绿假单胞菌:获得的危险因素及其对结局的影响
J Antimicrob Chemother. 2005 Apr;55(4):535-41. doi: 10.1093/jac/dki026. Epub 2005 Feb 22.
9
A five-year review of Pseudomonas aeruginosa bacteremia in children hospitalized at a single center in southern China.中国南方某单一中心医院儿童铜绿假单胞菌菌血症五年回顾。
Int J Infect Dis. 2012 Aug;16(8):e628-32. doi: 10.1016/j.ijid.2012.03.014. Epub 2012 Jun 17.
10
Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.碳青霉烯类耐药对铜绿假单胞菌血流感染死亡率及死亡率变化的影响。
Int J Infect Dis. 2010 Sep;14 Suppl 3:e73-8. doi: 10.1016/j.ijid.2009.11.019. Epub 2010 Mar 11.